Efthymios Stavropoulos
Overview
Explore the profile of Efthymios Stavropoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
325
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mavrogeni S, Gargani L, Pepe A, Monti L, Markousis-Mavrogenis G, De Santis M, et al.
Rheumatology (Oxford)
. 2019 Nov;
59(8):1938-1948.
PMID: 31764972
Objectives: Cardiac rhythm disturbances constitute the most frequent cardiovascular cause of death in SSc. However, electrocardiographic findings are not a part of risk stratification in SSc. We aimed to translate...
2.
Bratis K, Lindholm A, Hesselstrand R, Arheden H, Karabela G, Stavropoulos E, et al.
PLoS One
. 2019 Aug;
14(8):e0221021.
PMID: 31433819
Background: Impaired myocardial deformation has been sporadically described in cardiac asymptomatic systemic sclerosis (SSc). We aimed to study myocardial deformation indices in cardiac asymptomatic SSc patients using cardiac magnetic resonance...
3.
Mavrogeni S, Sfikakis P, Markousis-Mavrogenis G, Bournia V, Poulos G, Koutsogeorgopoulou L, et al.
Int J Cardiol
. 2018 Nov;
284:105-109.
PMID: 30404725
Background: Ventricular tachycardia/fibrillation (VT/VF) may occur in autoimmune rheumatic diseases (ARDs). We hypothesized that cardiovascular magnetic resonance (CMR) can identify arrhythmogenic substrates in ARD patients. Patients - Methods: Using a...
4.
Mavrogeni S, Koutsogeorgopoulou L, Karabela G, Stavropoulos E, Katsifis G, Raftakis J, et al.
BMC Cardiovasc Disord
. 2017 Jul;
17(1):187.
PMID: 28716007
Background: Systemic sclerosis (SSc) is an autoimmune disease characterized by microvascular abnormalities, inflammation and fibrosis. We hypothesized that myocarditis may be diagnosed in asymptomatic SSc, undergoing routine cardio-vascular magnetic resonance...
5.
Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas T, Bratis K, Kitas G, et al.
Int J Cardiol
. 2017 Feb;
236:151-156.
PMID: 28185705
Background-aim: Cardiac involvement at diagnosis of connective tissue disease (CTD) has been described by echocardiography. We hypothesized that cardio-vascular magnetic resonance (CMR) detects occult lesions at CTD diagnosis. Patients-methods: CMR...
6.
Mavrogeni S, Kitas G, Dimitroulas T, Sfikakis P, Seo P, Gabriel S, et al.
Int J Cardiol
. 2016 May;
217:135-48.
PMID: 27179903
Targeted therapies in connective tissue diseases (CTDs) have led to improvements of disease-associated outcomes, but life expectancy remains lower compared to general population due to emerging co-morbidities, particularly due to...
7.
Mavrogeni S, Karabela G, Koutsogeorgopoulou L, Stavropoulos E, Katsifis G, Plastiras S, et al.
Int J Cardiol
. 2016 Apr;
214:465-8.
PMID: 27096964
Background: Diffuse systemic sclerosis (dSSc) is characterized by vascular lesions and fibrosis. Cardiac involvement, although silent, accounts for 36% of deaths. We hypothesized that cardiovascular magnetic resonance (CMR) can clarify...
8.
Mavrogeni S, Sfikakis P, Dimitroulas T, Koutsogeorgopoulou L, Karabela G, Katsifis G, et al.
Inflamm Allergy Drug Targets
. 2016 Jan;
14(2):111-6.
PMID: 26728774
Background: To clarify the imaging patterns of cardiovascular lesions in patients with mixed connective tissue disease (MCTD) and cardiovascular symptoms with or/ without abnormal routine non-invasive evaluation. Patients-methods: Twenty-two MCTD...
9.
Mavrogeni S, Bratis K, Karabela G, Spiliotis G, van Wijk K, Hautemann D, et al.
Inflamm Allergy Drug Targets
. 2015 Sep;
14(1):29-36.
PMID: 26374223
Background: Myopericardial inflammation, perfusion's defects and fibrosis are major causes of cardiac disease in scleroderma (SSc). We hypothesized that using inflammation and stress perfusion-fibrosis cardiovascular magnetic resonance (CMR), we can...
10.
Mavrogeni S, Karabela G, Gialafos E, Spiliotis G, Pentazos G, Mylona M, et al.
Inflamm Allergy Drug Targets
. 2014 Nov;
13(5):335-8.
PMID: 25412817
Objectives: To evaluate the potential of cardiovascular magnetic resonance (CMR) to answer queries, addressed in systemic autoimmune diseases (SAD). Methods: Thirty-six patients aged 52±6 years, (range 27-71) with SAD and...